Free Trial

INmune Bio (INMB) SEC Filings & 10K Form

INmune Bio logo
$4.40 -0.02 (-0.45%)
(As of 12/20/2024 05:16 PM ET)

Recent INmune Bio SEC Filings

DateFilerForm TypeView
11/13/2024
5:08 AM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
3:23 PM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
3:00 PM
INmune Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2024
3:00 PM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
9:15 AM
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
INmune Bio (Subject)
Form SC 13G
10/24/2024
3:00 PM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
7:47 PM
INmune Bio (Issuer)
Moss David J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:48 PM
INmune Bio (Issuer)
Tesi Raymond Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
9:11 AM
INmune Bio (Filer)
Form 424B5
09/16/2024
9:15 AM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
11:15 PM
INmune Bio (Filer)
Form EFFECT
06/26/2024
7:00 AM
INmune Bio (Issuer)
Juda Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:05 PM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2024
3:30 PM
INmune Bio (Issuer)
Tesi Raymond Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:05 PM
INmune Bio (Filer)
Form DEF 14A
05/10/2024
6:46 PM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
3:05 PM
INmune Bio (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/26/2024
3:26 PM
INmune Bio (Filer)
Form 424B5
04/25/2024
3:35 PM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
1:07 PM
INmune Bio (Issuer)
Juda Scott (Reporting)
Form 4/A
04/24/2024
1:08 PM
INmune Bio (Issuer)
Lowdell Mark William (Reporting)
Form 4/A
04/24/2024
1:08 PM
INmune Bio (Issuer)
Tesi Raymond Joseph (Reporting)
Form 4/A
04/24/2024
1:10 PM
INmune Bio (Issuer)
Moss David J (Reporting)
Form 4/A
04/23/2024
4:53 PM
INmune Bio (Issuer)
Juda Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
4:54 PM
INmune Bio (Issuer)
Lowdell Mark William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
4:54 PM
INmune Bio (Issuer)
Moss David J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
4:55 PM
INmune Bio (Issuer)
Tesi Raymond Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
4:09 PM
INmune Bio (Filer)
Form 424B5
04/22/2024
4:10 PM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2024
3:58 PM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:06 PM
INmune Bio (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/30/2024
7:02 AM
INmune Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:INMB) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners